| # | Drug | Count |
|---|---|---|
| 0 | TESTOSTERONE CYPIONATE | 36 |
| 1 | TESTOSTERONE | 11 |
| 2 | INSULIN ASPART | 8 |
| 3 | INSULIN ASPART INJECTION | 8 |
| 4 | INSULIN GLULISINE | 8 |
| 5 | OXYCODONE HYDROCHLORIDE | 5 |
| 6 | ASPIRIN | 4 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | NALTREXONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TESTOSTERONE CYPIONATE | 36 | 0.0040 |
| 1 | TOVORAFENIB | 1 | 0.0031 |
| 2 | INSULIN ASPART INJECTION | 8 | 0.0029 |
| 3 | LEVONORGESTREL/ETHINYL ESTRADIOL | 2 | 0.0018 |
| 4 | PORACTANT ALFA | 1 | 0.0014 |
| 5 | RILONACEPT | 1 | 0.0009 |
| 6 | INSULIN GLULISINE | 8 | 0.0008 |
| 7 | TESTOSTERONE | 11 | 0.0005 |
| 8 | NEPAFENAC | 1 | 0.0003 |
| 9 | ARIPIPRAZOLE LAUROXIL | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 17 |
| 1 | Androgen [EPC] | 11 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 4 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 5 | Estrogen [EPC] | 2 |
| 6 | Human Immunoglobulin G [EPC] | 2 |
| 7 | Progestin [EPC] | 2 |
| 8 | Progestin-containing Intrauterine System [EPC] | 2 |
| 9 | Vitamin C [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 1 | 0.0009 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Androgen [EPC] | 11 | 0.0004 |
| 3 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Insulin Analog [EPC] | 17 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |